vs
NLIGHT, INC.（LASR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
NLIGHT, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$81.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -6.0%，领先390.1%），NLIGHT, INC.同比增速更快（71.3% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 35.0%）
nLight Inc.是全球领先的高性能半导体激光器、光纤激光器及相关光学组件研发生产商，产品广泛应用于工业精密制造、航空航天与国防、医疗设备、前沿研究等核心领域，客户遍及北美、欧洲及亚太地区。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LASR vs RIGL — 直观对比
营收规模更大
LASR
是对方的1.2倍
$69.8M
营收增速更快
LASR
高出50.2%
21.2%
净利率更高
RIGL
高出390.1%
-6.0%
两年增速更快
RIGL
近两年复合增速
35.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $69.8M |
| 净利润 | $-4.9M | $268.1M |
| 毛利率 | 30.7% | 91.5% |
| 营业利润率 | -6.7% | 33.2% |
| 净利率 | -6.0% | 384.0% |
| 营收同比 | 71.3% | 21.2% |
| 净利润同比 | 80.3% | 1769.2% |
| 每股收益（稀释后） | $-0.10 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LASRRIGL
| Q4 25 | $81.2M | $69.8M | ||
| Q3 25 | $66.7M | $69.5M | ||
| Q2 25 | $61.7M | $101.7M | ||
| Q1 25 | $51.7M | $53.3M | ||
| Q4 24 | $47.4M | $57.6M | ||
| Q3 24 | $56.1M | $55.3M | ||
| Q2 24 | $50.5M | $36.8M | ||
| Q1 24 | $44.5M | $29.5M |
净利润LASRRIGL
| Q4 25 | $-4.9M | $268.1M | ||
| Q3 25 | $-6.9M | $27.9M | ||
| Q2 25 | $-3.6M | $59.6M | ||
| Q1 25 | $-8.1M | $11.4M | ||
| Q4 24 | $-25.0M | $14.3M | ||
| Q3 24 | $-10.3M | $12.4M | ||
| Q2 24 | $-11.7M | $-1.0M | ||
| Q1 24 | $-13.8M | $-8.2M |
毛利率LASRRIGL
| Q4 25 | 30.7% | 91.5% | ||
| Q3 25 | 31.1% | 93.2% | ||
| Q2 25 | 29.9% | 95.6% | ||
| Q1 25 | 26.7% | 91.7% | ||
| Q4 24 | 2.4% | 89.9% | ||
| Q3 24 | 22.4% | 85.5% | ||
| Q2 24 | 23.5% | 92.4% | ||
| Q1 24 | 16.8% | 93.1% |
营业利润率LASRRIGL
| Q4 25 | -6.7% | 33.2% | ||
| Q3 25 | -10.9% | 40.9% | ||
| Q2 25 | -6.9% | 60.1% | ||
| Q1 25 | -18.6% | 23.9% | ||
| Q4 24 | -55.8% | 28.9% | ||
| Q3 24 | -21.0% | 25.4% | ||
| Q2 24 | -25.1% | 1.2% | ||
| Q1 24 | -33.1% | -23.6% |
净利率LASRRIGL
| Q4 25 | -6.0% | 384.0% | ||
| Q3 25 | -10.3% | 40.2% | ||
| Q2 25 | -5.8% | 58.6% | ||
| Q1 25 | -15.7% | 21.5% | ||
| Q4 24 | -52.7% | 24.9% | ||
| Q3 24 | -18.4% | 22.5% | ||
| Q2 24 | -23.2% | -2.8% | ||
| Q1 24 | -30.9% | -27.9% |
每股收益（稀释后）LASRRIGL
| Q4 25 | $-0.10 | $14.11 | ||
| Q3 25 | $-0.14 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.16 | $0.63 | ||
| Q4 24 | $-0.52 | $0.82 | ||
| Q3 24 | $-0.21 | $0.70 | ||
| Q2 24 | $-0.25 | $-0.06 | ||
| Q1 24 | $-0.29 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $226.7M | $391.5M |
| 总资产 | $315.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LASRRIGL
| Q4 25 | $98.7M | $155.0M | ||
| Q3 25 | $81.1M | $137.1M | ||
| Q2 25 | $78.8M | $108.4M | ||
| Q1 25 | $82.2M | $77.1M | ||
| Q4 24 | $65.8M | $77.3M | ||
| Q3 24 | $41.5M | $61.1M | ||
| Q2 24 | $49.4M | $49.1M | ||
| Q1 24 | $61.3M | $49.5M |
总债务LASRRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益LASRRIGL
| Q4 25 | $226.7M | $391.5M | ||
| Q3 25 | $218.5M | $117.6M | ||
| Q2 25 | $216.0M | $81.9M | ||
| Q1 25 | $212.8M | $18.6M | ||
| Q4 24 | $216.4M | $3.3M | ||
| Q3 24 | $235.3M | $-14.6M | ||
| Q2 24 | $239.5M | $-29.9M | ||
| Q1 24 | $244.4M | $-31.7M |
总资产LASRRIGL
| Q4 25 | $315.2M | $513.6M | ||
| Q3 25 | $298.7M | $242.5M | ||
| Q2 25 | $295.3M | $206.7M | ||
| Q1 25 | $290.0M | $176.0M | ||
| Q4 24 | $270.2M | $164.0M | ||
| Q3 24 | $291.3M | $139.4M | ||
| Q2 24 | $294.3M | $128.4M | ||
| Q1 24 | $302.8M | $126.5M |
负债/权益比LASRRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $15.9M | — |
| 自由现金流率自由现金流/营收 | 19.6% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $12.3M | — |
8季度趋势，按日历期对齐
经营现金流LASRRIGL
| Q4 25 | $17.5M | $22.0M | ||
| Q3 25 | $5.2M | $24.0M | ||
| Q2 25 | $-1.4M | $30.5M | ||
| Q1 25 | $-20.0K | $-893.0K | ||
| Q4 24 | $-3.9M | $14.5M | ||
| Q3 24 | $-5.6M | $21.7M | ||
| Q2 24 | $-4.2M | $302.0K | ||
| Q1 24 | $11.4M | $-5.0M |
自由现金流LASRRIGL
| Q4 25 | $15.9M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.4M | — | ||
| Q1 24 | $9.8M | — |
自由现金流率LASRRIGL
| Q4 25 | 19.6% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | -6.1% | — | ||
| Q1 25 | -4.5% | — | ||
| Q4 24 | -13.7% | — | ||
| Q3 24 | -12.9% | — | ||
| Q2 24 | -12.6% | — | ||
| Q1 24 | 22.1% | — |
资本支出强度LASRRIGL
| Q4 25 | 2.0% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 3.5% | — |
现金转化率LASRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LASR
| Aerospaceand Defense | $56.3M | 69% |
| Microfabrication | $14.2M | 18% |
| Industrial | $10.7M | 13% |
RIGL
暂无分部数据
